Didier Mary

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Chronic Myeloid Leukemia

Replacement Therapy

Endoplasmic Reticulum Stress

Top Venues

International journal of molecular sciences

INSERM

This page only lists publications with an associated author ORCID identifier.

Affiliation History

INSERM Apr 01 1991

France

CRCN

Publications

Fabien Muselli, Lucas Mourgues, Nathalie Rochet, Marielle Nebout, Agnès Guerci, Els Verhoeyen, Adrien Krug, Laurence Legros, Jean-François Peyron, Didier Mary
Repurposing the Bis-Biguanide Alexidine in Combination with Tyrosine Kinase Inhibitors to Eliminate Leukemic Stem/Progenitor Cells in Chronic Myeloid Leukemia. Cancers 15 (3) (2023)
Fabien Muselli, Lucas Mourgues, Nathalie Rochet, Marielle Nebout, Agnès Guerci, Els Verhoeyen, Adrien Krug, Laurence Legros, Jean-François Peyron, Didier Mary
Repurposing the Bis-Biguanide Alexidine in Combination with Tyrosine Kinase Inhibitors to Eliminate Leukemic Stem/Progenitor Cells in Chronic Myeloid Leukemia. Cancers 15 (3) (2023)
Fabien Muselli, Lucas Mourgues, Rita Morcos, Nathalie Rochet, Marielle Nebout, Agnès Guerci-Bresler, Douglas V Faller, Robert M William, Rana Mhaidly, Els Verhoeyen, Laurence Legros, Jean-François Peyron, Didier Mary
Combination of PKCδ Inhibition with Conventional TKI Treatment to Target CML Models. Cancers 13 (7) (2021)
Fabien Muselli, Jean-François Peyron, Didier Mary
Druggable Biochemical Pathways and Potential Therapeutic Alternatives to Target Leukemic Stem Cells and Eliminate the Residual Disease in Chronic Myeloid Leukemia. International journal of molecular sciences 20 (22) (2019)